Spasticity - Epidemiology Forecast - 2027

  • ID: 4471032
  • Report
  • 78 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
The “Spasticity – Epidemiology Forecast, 2027” report provides an overview of the disease along with global historical and forecasted epidemiological data of Spasticity for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan till 2027.

Overview of the Epidemiology

The report covers the disease overview including its symptoms, risk factors, causes, diagnosis and prevalence of Spasticity in the seven major markets. It also includes the management and treatment approaches for the treatment of Spasticity. It further covers the detailed global historical and forecasted epidemiological data covering the seven major markets from 2015-2027. The seven major markets include United States, EU5 (France, Germany, Italy, Spain, UK) and one Asian country Japan.

The report includes the overall prevalence of Spasticity in relation to ALS, Cerebral Palsy, Meningitis, Post Stroke and Traumatic Brain Injury in the 7MM- United States, EU5 (France, Germany, Italy, Spain and UK) and Japan.

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Key Coverage and Benefits
  • The Report includes the prevalent population and how will it change over the next ten years.
  • Coverage of key Spasticity sub-populations and its prevalent cases
  • Prevalent cases segmented by relating to ALS, Cerebral Palsy, Meningitis, Post Stroke and Traumatic Brain Injury
  • The key differences in epidemiology patterns across the seven market segments
Reasons to buy
  • Developing business strategies by understanding the trends shaping and driving the global Spasticity market
  • Identifying prevalent patient populations as well as risk factors in the global Spasticity market will help to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the best opportunities for Spasticity therapeutics in each of the markets covered
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Overview
Symptoms
Diagnosis
Pathophysiology
Spasticity in Cerebral Palsy
Spasticity in Multiple Sclerosis
Spasticity in Traumatic Brain Injury
Spasticity in Meningitis
Spasticity in Amyotrophic Lateral Sclerosis
Post Stroke Spasticity
Treatment
Epidemiology- 7MM
Key Findings
Epidemiology of Spasticity in 7 MM
Assumptions and Rationale
Prevalent Population of Spasticity in 7MM
United States
Assumptions and Rationale
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
EU
Assumptions and Rationale
United Kingdom
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
France
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
Germany
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
Italy
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
Spain
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
Japan
Assumptions and Rationale
Prevalent Population of Spasticity
Gender Specific Spasticity Prevalence
Spasticity Prevalence in ALS
Spasticity Prevalence in Cerebral Palsy
Spasticity Prevalence in Meningitis
Spasticity Prevalence in Multiple Sclerosis
Spasticity Prevalence in Post Stroke
Spasticity Prevalence in Traumatic Brain Injury
Appendix

List of Tables:
Table 1: 7MM, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 2: United States, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 3: United States, Gender Specific Spasticity Prevalence, 2015-20
Table 4: United Kingdom, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 5: United Kingdom, Gender Specific Spasticity Prevalence, 2015-20
Table 6: France, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 7: France, Gender Specific Spasticity Prevalence, 2015-20
Table 8: Germany, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 9: Germany, Gender Specific Spasticity Prevalence, 2015-20
Table 10: Italy, Historical & Projected Prevalence of Spasticity Prevalence, 2015-20
Table 11: Italy, Gender Specific Spasticity Prevalence, 2015-20
Table 12: Spain, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 13: Spain, Gender Specific Spasticity Prevalence, 2015-20
Table 14: Japan, Historical & Forecasted Spasticity Prevalence, 2015-20
Table 15: Japan, Gender Specific Spasticity Prevalence, 2015-20

List of Figures:
Figure 1: 7MM, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 2: United States, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 3: United States, Gender Specific Spasticity Prevalence, 2015-20
Figure 4: United States, Spasticity Prevalence in ALS, 2015-20
Figure 5: United States, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 6: United States, Spasticity Prevalence in Meningitis, 2015-20
Figure 7: United States, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 8: United States, Spasticity Prevalence in Post Stroke, 2015-20
Figure 9: United States, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Figure 10: United Kingdom, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 11: United Kingdom, Gender Specific Spasticity Prevalence, 2015-20
Figure 12: United Kingdom, Spasticity Prevalence in ALS, 2015-20
Figure 13: United Kingdom, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 14: United Kingdom, Spasticity Prevalence in Meningitis, 2015-20
Figure 15: United Kingdom, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 16: United Kingdom, Spasticity Prevalence in Post Stroke, 2015-20
Figure 17: United Kingdom, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Figure 18: France, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 19: France, Gender Specific Spasticity Prevalence, 2015-20
Figure 20: France, Spasticity Prevalence in ALS, 2015-20
Figure 21: France, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 22: France, Spasticity Prevalence in Meningitis, 2015-20
Figure 23: France, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 24: France, Spasticity Prevalence in Post Stroke, 2015-20
Figure 25: France, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Figure 26: Germany, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 27: Germany, Gender Specific Spasticity Prevalence, 2015-20
Figure 28: Germany, Spasticity Prevalence in ALS, 2015-20
Figure 29: Germany, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 30: Germany, Spasticity Prevalence in Meningitis, 2015-20
Figure 31: Germany, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 32: Germany, Spasticity Prevalence in Post Stroke, 2015-20
Figure 33: Germany, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Figure 34: Italy, Historical & Projected Prevalence of Spasticity Prevalence, 2015-20
Figure 35: Italy, Gender Specific Spasticity Prevalence, 2015-20
Figure 36: Italy, Spasticity Prevalence in ALS, 2015-20
Figure 37: Italy, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 38: Italy, Spasticity Prevalence in Meningitis, 2015-20
Figure 39: Italy, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 40: Italy, Spasticity Prevalence in Post Stroke, 2015-20
Figure 41: Italy, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Figure 42: Spain, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 43: Spain, Gender Specific Spasticity Prevalence, 2015-20
Figure 44: Spain, Spasticity Prevalence in ALS, 2015-20
Figure 45: Spain, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 46: Spain, Spasticity Prevalence in Meningitis, 2015-20
Figure 47: Spain, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 48: Spain, Spasticity Prevalence in Post Stroke, 2015-20
Figure 49: Spain, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Figure 50: Japan, Historical & Forecasted Spasticity Prevalence, 2015-20
Figure 51: Japan, Gender Specific Spasticity Prevalence, 2015-20
Figure 52: Japan, Spasticity Prevalence in ALS, 2015-20
Figure 53: Japan, Spasticity Prevalence in Cerebral Palsy, 2015-20
Figure 54: Japan, Spasticity Prevalence in Meningitis, 2015-20
Figure 55: Japan, Spasticity Prevalence in Multiple Sclerosis, 2015-20
Figure 56: Japan, Spasticity Prevalence in Post Stroke, 2015-20
Figure 57: Japan, Spasticity Prevalence in Traumatic Brain Injury, 2015-20
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll